IP Library Granted Patent US 9,719,081
Granted Patent B2
US 9,719,081 · App. 15/002,013 · Granted Aug 1, 2017

Thermostable blunt-end ligase and methods of use

Inventor: Frederick Christians (Palo Alto, CA)
Assignee: Theranos, Inc.
C12N9/93C12P19/34C12Y605/01001C07K2319/21C07K2319/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,719,081
App. No.
15/002,013
Granted
Aug 1, 2017
Kind
B2
Abstract

Fusion proteins having thermostable blunt-end ligase activity are provided. Blunt-end ligases are useful for DNA amplification, sequencing, production of recombinant DNA and recombinant fusion proteins, and other purposes. These thermostable blunt-end DNA ligases are useful in ligation schemes which include, e.g., an incubation at about 60-65° C. or higher, or as high as about 94° C., or at other temperatures. The ligases disclosed herein may enable high temperature blunt-end ligation without need for molecular crowding agents, and so may be useful for many nucleic acid ligation-amplification schemes, e.g., ones which operate at a uniform temperature (e.g., at about 60° C. or higher), including ones which require temperature cycling, e.g., from about 94° C. to about 60° C. (or higher) for one, two, three, or more cycles. The thermostable blunt-end DNA ligases disclosed herein enable higher specificity target amplification, for example, by permitting temperature denaturation of double-stranded DNA templates as well as specific primer binding.

Claims (22)

1. A method of performing a blunt-end DNA ligase reaction, comprising:

Combining DNA molecules to be ligated and a thermostable blunt-end DNA ligase in a solution, wherein said thermostable blunt-end DNA ligase comprises the amino acid sequence: mghhhhhhhhhhssghiegrasadgpylqileqpkqrgfrfryvcegpshgglpgasseknkksypqvkicnyvgpakvivqlvtn gknihlhahslvgkhcedgictvtagpkdmvvgfanlgilhvtkkkvfetlearmteacirgynpgllvhpdlaylqaegggdrqlgdr ekelirqaalqqtkemdlsvvrlmftaflpdstgsftrrlepvvsdaiydskapnasnlkivrmdrtagcvtggeeiyllcdkvqkddiqir fyeeeenggvwegfgdfsptdvhrqfaivfkpkykdinitkpasvfvqlrrksdletsepkpflyypeikdkeevqrkrqkgssgtsg ggsgggmtleearkrvnelrdliryhnyryyvladpeisdaeydrllrelkeleerfpelkspdsptlqvgarpleatfrpvrhptrmysld nafnldelkafeerieralgrkgpfaytvehkvdglsvnlyyeegylvygatrgdgevgeevtqnlltiptiprrlkgvperlevrgevym pieaflrineeleergerifknprnaaagslrqkdpritakrglratfyalglgleeveregvatqfallhwlkekgfpvehgyaravgaegv eavyqdwlkkrralpfeadgvvvkldelalwrelgytaraprfaiaykfpaeeketrlldvvfqvgrtgrvtpvgilepvflegsevsrvtl hnesyieeldirigdwvlvhkaggvipevlrvlkerrtgeerpirwpetcpecghrllkegkvhrcpnplcpakrfeairhfasrkamdi qglgeklierllekglvkdvadlyrlrkedlvglermgeksaqnllrqieeskkrglerllyalglpgvgevlarnlaarfgnmdrlleasle elleveevgeltarailetlkdpafrdlvrrlkeagvemeakekggealkgltfvitgelsrpreevkallrrlgakvtdsysrktsylvvgen pgsklekaralgvptlteeelyffleartgkkaeelv (SEQ ID NO: 8); and

performing a blunt-ended DNA ligation reaction at a temperature of about 60° C. or higher.

2. The method of claim 1 , wherein said thermostable blunt-end DNA ligase reaction is performed at a temperature of about 60° C. or higher is performed at a uniform temperature.

3. The method of claim 1 , wherein said thermostable blunt-end DNA ligase reaction is performed at a temperature of about 60° C. to about 65° C.

4. The method of claim 1 , wherein said thermostable blunt-end DNA ligase reaction is performed at a temperature of about 75° C.

5. The method of claim 1 , wherein said thermostable blunt-end DNA ligase reaction comprises temperature cycling.

6. The method of claim 1 , wherein said thermostable blunt-end DNA ligase reaction comprises temperature cycling from about 94° C. to about 60° C.

7. The method of claim 1 , wherein said thermostable blunt-end DNA ligase reaction comprises two or more cycles of temperature cycling.

8. The method of claim 1 , wherein said thermostable blunt-end DNA ligase reaction comprises two or more cycles of temperature cycling from about 94° C. to about 60° C.

9. The method of claim 1 , wherein said thermostable blunt-end DNA ligase reaction comprises three or more cycles of temperature cycling.

10. The method of claim 1 , wherein said thermostable blunt-end DNA ligase reaction comprises three or more cycles of temperature cycling from about 94° C. to about 60° C.

11. The method of claim 1 , wherein said thermostable blunt-end DNA ligase comprises a fusion protein comprising a polymer.

12. The method of claim 1 , wherein said thermostable blunt-end DNA ligase comprises a fusion protein comprising a sugar.

13. The method of claim 1 , wherein said thermostable blunt-end DNA ligase comprises a fusion protein comprising a sugar and comprising a polymer.

14. The method of claim 1 , wherein said thermostable blunt-end DNA ligase comprises a fusion protein comprising a component selected from a peptide linker, an N-terminal addition, a C-terminal addition, and a peptide mimetic.

15. The method of claim 14 , wherein said method is performed at about 60° C. to about 65° C.

16. The method of claim 14 , wherein said thermostable blunt-end DNA ligase comprises a fusion protein comprising a sugar and comprising a polymer.

17. The method of claim 14 , wherein said thermostable blunt-end DNA ligase comprises an affinity tag comprising polyhistidine.

18. The method of claim 1 , comprising multiple ligation events effective to provide concatamers.

19. The method of claim 18 , wherein said multiple ligation events effective to provide concatamers are performed at about 75° C.

20. The method of claim 18 , wherein said thermostable blunt-end DNA ligase comprises a fusion protein comprising a component selected from a peptide linker, an N-terminal addition, a C-terminal addition, and a peptide mimetic.

Assignments (5)
CHANGE OF NAME Recorded Apr 3, 2020
From: THERANOS IP COMPANY, LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052313/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 045101/0315 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: THERANOS INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 044838/0909 →
SECURITY INTEREST Recorded Dec 12, 2017
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 044839/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2016
From: CHRISTIANS, FREDERICK
To: THERANOS, INC.
Reel/Frame 037565/0876 →
Continuity (3)
Continuation 14214834 · Mar 15, 2014
Provisional Application 61802124 · Mar 15, 2013
Related Publication 20170015989A1 · Jan 19, 2017